164 related articles for article (PubMed ID: 11500389)
1. Selection of glutamate-rich protein long synthetic peptides for vaccine development: antigenicity and relationship with clinical protection and immunogenicity.
Theisen M; Dodoo D; Toure-Balde A; Soe S; Corradin G; Koram KK; Kurtzhals JA; Hviid L; Theander T; Akanmori B; Ndiaye M; Druilhe P
Infect Immun; 2001 Sep; 69(9):5223-9. PubMed ID: 11500389
[TBL] [Abstract][Full Text] [Related]
2. Cytophilic immunoglobulin responses to Plasmodium falciparum glutamate-rich protein are correlated with protection against clinical malaria in Dielmo, Senegal.
Oeuvray C; Theisen M; Rogier C; Trape JF; Jepsen S; Druilhe P
Infect Immun; 2000 May; 68(5):2617-20. PubMed ID: 10768952
[TBL] [Abstract][Full Text] [Related]
3. Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein.
Soe S; Theisen M; Roussilhon C; Aye KS; Druilhe P
Infect Immun; 2004 Jan; 72(1):247-52. PubMed ID: 14688102
[TBL] [Abstract][Full Text] [Related]
4. Antibody response profiles induced by Plasmodium falciparum glutamate-rich protein in naturally exposed individuals from a Brazilian area endemic for malaria.
Pratt-Riccio LR; Lima-Junior JC; Carvalho LJ; Theisen M; Espíndola-Mendes EC; Santos F; Oliveira-Ferreira J; Goldberg AC; Daniel-Ribeiro CT; Banic DM
Am J Trop Med Hyg; 2005 Dec; 73(6):1096-103. PubMed ID: 16354819
[TBL] [Abstract][Full Text] [Related]
5. Humoral immune response to Plasmodium falciparum vaccine candidate GMZ2 and its components in populations naturally exposed to seasonal malaria in Ethiopia.
Mamo H; Esen M; Ajua A; Theisen M; Mordmüller B; Petros B
Malar J; 2013 Feb; 12():51. PubMed ID: 23383869
[TBL] [Abstract][Full Text] [Related]
6. Long synthetic peptides encompassing the Plasmodium falciparum LSA3 are the target of human B and T cells and are potent inducers of B helper, T helper and cytolytic T cell responses in mice.
Perlaza BL; Sauzet JP; Balde AT; Brahimi K; Tall A; Corradin G; Druilhe P
Eur J Immunol; 2001 Jul; 31(7):2200-9. PubMed ID: 11449374
[TBL] [Abstract][Full Text] [Related]
7. Natural antibody responses to Plasmodium falciparum MSP3 and GLURP(R0) antigens are associated with low parasite densities in malaria patients living in the Central Region of Ghana.
Amoah LE; Nuvor SV; Obboh EK; Acquah FK; Asare K; Singh SK; Boampong JN; Theisen M; Williamson KC
Parasit Vectors; 2017 Aug; 10(1):395. PubMed ID: 28835262
[TBL] [Abstract][Full Text] [Related]
8. Antigenicity and immunogenicity of recombinant glutamate-rich protein of Plasmodium falciparum expressed in Escherichia coli.
Theisen M; Vuust J; Gottschau A; Jepsen S; Høgh B
Clin Diagn Lab Immunol; 1995 Jan; 2(1):30-4. PubMed ID: 7719909
[TBL] [Abstract][Full Text] [Related]
9. Pre-clinical assessment of novel multivalent MSP3 malaria vaccine constructs.
Bang G; Prieur E; Roussilhon C; Druilhe P
PLoS One; 2011; 6(12):e28165. PubMed ID: 22145028
[TBL] [Abstract][Full Text] [Related]
10. The glutamate-rich protein (GLURP) of Plasmodium falciparum is a target for antibody-dependent monocyte-mediated inhibition of parasite growth in vitro.
Theisen M; Soe S; Oeuvray C; Thomas AW; Vuust J; Danielsen S; Jepsen S; Druilhe P
Infect Immun; 1998 Jan; 66(1):11-7. PubMed ID: 9423833
[TBL] [Abstract][Full Text] [Related]
11. Recognition of synthetic 104-mer and 102-mer peptides corresponding to N- and C-terminal nonrepeat regions of the Plasmodium falciparum circumsporozoite protein by sera from human donors.
Lopez JA; Roggero MA; Duombo O; Gonzalez JM; Tolle R; Koita O; Arevalo-Herrera M; Herrera S; Corradin G
Am J Trop Med Hyg; 1996 Oct; 55(4):424-9. PubMed ID: 8916800
[TBL] [Abstract][Full Text] [Related]
12. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.
Perraut R; Varela ML; Joos C; Diouf B; Sokhna C; Mbengue B; Tall A; Loucoubar C; Touré A; Mercereau-Puijalon O
Vaccine; 2017 Dec; 35(48 Pt B):6720-6726. PubMed ID: 29042203
[TBL] [Abstract][Full Text] [Related]
13. Naturally acquired antibodies to the glutamate-rich protein are associated with protection against Plasmodium falciparum malaria.
Dodoo D; Theisen M; Kurtzhals JA; Akanmori BD; Koram KA; Jepsen S; Nkrumah FK; Theander TG; Hviid L
J Infect Dis; 2000 Mar; 181(3):1202-5. PubMed ID: 10720556
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of well-characterized synthetic Plasmodium falciparum multiple antigen peptide conjugates.
Joshi MB; Gam AA; Boykins RA; Kumar S; Sacci J; Hoffman SL; Nakhasi HL; Kenney RT
Infect Immun; 2001 Aug; 69(8):4884-90. PubMed ID: 11447164
[TBL] [Abstract][Full Text] [Related]
15. Differential antibody recognition of four allelic variants of the merozoite surface protein-2 (MSP-2) of Plasmodium falciparum.
Tonhosolo R; Wunderlich G; Ferreira MU
J Eukaryot Microbiol; 2001; 48(5):556-64. PubMed ID: 11596920
[TBL] [Abstract][Full Text] [Related]
16. Naturally acquired antibody response to a Plasmodium falciparum chimeric vaccine candidate GMZ2.6c and its components (MSP-3, GLURP, and Pfs48/45) in individuals living in Brazilian malaria-endemic areas.
Baptista BO; de Souza ABL; Riccio EKP; Bianco-Junior C; Totino PRR; Martins da Silva JH; Theisen M; Singh SK; Amoah LE; Ribeiro-Alves M; Souza RM; Lima-Junior JC; Daniel-Ribeiro CT; Pratt-Riccio LR
Malar J; 2022 Jan; 21(1):6. PubMed ID: 34983540
[TBL] [Abstract][Full Text] [Related]
17. Plasmodium falciparum synthetic LbL microparticle vaccine elicits protective neutralizing antibody and parasite-specific cellular immune responses.
Powell TJ; Tang J; Derome ME; Mitchell RA; Jacobs A; Deng Y; Palath N; Cardenas E; Boyd JG; Nardin E
Vaccine; 2013 Apr; 31(15):1898-904. PubMed ID: 23481177
[TBL] [Abstract][Full Text] [Related]
18. Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial.
Hermsen CC; Verhage DF; Telgt DS; Teelen K; Bousema JT; Roestenberg M; Bolad A; Berzins K; Corradin G; Leroy O; Theisen M; Sauerwein RW
Vaccine; 2007 Apr; 25(15):2930-40. PubMed ID: 16914240
[TBL] [Abstract][Full Text] [Related]
19. Evidence for multiple B- and T-cell epitopes in Plasmodium falciparum liver-stage antigen 3.
Toure-Balde A; Perlaza BL; Sauzet JP; Ndiaye M; Aribot G; Tall A; Sokhna C; Rogier C; Corradin G; Roussilhon C; Druilhe P
Infect Immun; 2009 Mar; 77(3):1189-96. PubMed ID: 19139199
[TBL] [Abstract][Full Text] [Related]
20. Plasmodium falciparum merozoite surface antigen-specific cytophilic IgG and control of malaria infection in a Beninese birth cohort.
Adamou R; Dechavanne C; Sadissou I; d'Almeida T; Bouraima A; Sonon P; Amoussa R; Cottrell G; Le Port A; Theisen M; Remarque EJ; Longacre S; Moutairou K; Massougbodji A; Luty AJF; Nuel G; Migot-Nabias F; Sanni A; Garcia A; Milet J; Courtin D
Malar J; 2019 Jun; 18(1):194. PubMed ID: 31185998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
